Rationale and Design of the First Double-Blind , Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart

Jens Kastrup,Morten Schou,Ida Gustafsson,Olav W. Nielsen,Rasmus Møgelvang,Klaus F. Kofoed,Charlotte Kragelund,Jens Dahlgaard Hove,Andreas Fabricius-Bjerre, Merete Heitman,Mandana Haack-Sørensen,Lisbeth Drozd Lund,Ellen Mønsted Johansen,Abbas Ali Qayyum,Anders Bruun Mathiasen,Annette Ekblond

semanticscholar（2017）

Cited 0|Views5

No score

Abstract

Citation for published version (APA): Kastrup, J., Schou, M., Gustafsson, I., Nielsen, O. W., Møgelvang, R., Kofoed, K. F., ... Ekblond, A. (2017). Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem Cells International, 2017, [8506370]. https://doi.org/10.1155/2017/8506370

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined